Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting
the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. .
Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel
therapeutics having minimal side effects and economic pricing.
Multiple Sclerosis Market Covers the Table of Contents With Segments, Key Players And Region. Based
on treatment modality, Multiple Sclerosis Market is sub segmented into intoinjectable agents and oral
agents.
Major Players profiled in the Multiple Sclerosis Market report incorporate: Biogen Idec, Novartis, EMD
Serono, Sanofi, Teva Pharmaceutical, Bayer, Pfizer, Synthetic Biologic, Active Biotech, and Opexa.
Latest Industry News
1 Novartis today announced results from a validation study of the innovative, algorithm-based digital
solution MS Progression Discussion Tool, or MSProDiscussTM. The tool aims to support and facilitate a
discussion between physicians and patients living with multiple sclerosis (MS) who have transitioned, or
are at risk of transitioning from relapsing remitting MS (RRMS) to secondary progressive MS (SPMS).
Diagnosing SPMS can be challenging but if carried out in a timely manner, could help to prevent further
irreversible damage. The study findings, presented today at the 2019 American Academy of Neurology
Annual Meeting (AAN) in Philadelphia, Pennsylvania, USA, support the validity and potential use of
MSProDiscussTM to help evaluate and discuss early signs suggestive of progression in clinical practice.
MS neurologists in the United States, Canada, and Germany tested the tool with 198 patients with a
diagnosis of RRMS, SPMS or a suspected transition to SPMS. In the validation study, physicians went
through a series of weighted questions with the patients based on their experience in the last six
months. The questions aim to gather information on symptoms and how they impact daily life and
activities. Once completed, the algorithm generated a visual output that the physicians could use to
facilitate a discussion around the level of disease progression. The results from the validation study
demonstrated that MSProDiscussTM was able to differentiate between RRMS and SPMS patients with
high sensitivity and specificity and thus also inform about patients in transition.
Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents on
“Global Multiple Sclerosis Market Report 2019” @ https://www.businessindustryreports.com/buy-
now/162970/single .
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Multiple Sclerosis in these regions, from 2014 to 2023 (forecast), covering:
North America, Europe, Asia Pacific, Middle East & Africa and South America.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.